The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Multiple Organ Failure

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Multiple Organ Failure


High impact information on Multiple Organ Failure


Chemical compound and disease context of Multiple Organ Failure


Biological context of Multiple Organ Failure


Anatomical context of Multiple Organ Failure


Gene context of Multiple Organ Failure


Analytical, diagnostic and therapeutic context of Multiple Organ Failure


  1. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. Zhao, Q., Wang, X., Nelin, L.D., Yao, Y., Matta, R., Manson, M.E., Baliga, R.S., Meng, X., Smith, C.V., Bauer, J.A., Chang, C.H., Liu, Y. J. Exp. Med. (2006) [Pubmed]
  2. The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. Anderson, J.A., Lentsch, A.B., Hadjiminas, D.J., Miller, F.N., Martin, A.W., Nakagawa, K., Edwards, M.J. J. Clin. Invest. (1996) [Pubmed]
  3. Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies. Saba, T.M., Niehaus, G.D., Scovill, W.A., Blumenstock, F.A., Newell, J.C., Holman, J., Powers, S.R. Ann. Surg. (1983) [Pubmed]
  4. A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction. Presneill, J.J., Harris, T., Stewart, A.G., Cade, J.F., Wilson, J.W. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  5. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Ueda, S., Nishio, K., Minamino, N., Kubo, A., Akai, Y., Kangawa, K., Matsuo, H., Fujimura, Y., Yoshioka, A., Masui, K., Doi, N., Murao, Y., Miyamoto, S. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  6. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Chen, L.W., Egan, L., Li, Z.W., Greten, F.R., Kagnoff, M.F., Karin, M. Nat. Med. (2003) [Pubmed]
  7. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. Meduri, G.U., Headley, A.S., Golden, E., Carson, S.J., Umberger, R.A., Kelso, T., Tolley, E.A. JAMA (1998) [Pubmed]
  8. Multiple organ dysfunction syndrome in bone marrow transplantation. Haire, W.D., Ruby, E.I., Gordon, B.G., Patil, K.D., Stephens, L.C., Kotulak, G.D., Reed, E.C., Vose, J.M., Bierman, P.J., Kessinger, A. JAMA (1995) [Pubmed]
  9. C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Liu, D., Zhang, D., Scafidi, J., Wu, X., Cramer, C.C., Davis, A.E. Blood (2005) [Pubmed]
  10. Mitogen-activated protein kinases in the intensive care unit: prognostic potential. Rosengart, M.R., Nathens, A.B., Arbabi, S., Neff, M.J., Garcia, I., Martin, T.R., Maier, R.V. Ann. Surg. (2003) [Pubmed]
  11. Transcription factor NF kappa B expression and postsurgical organ dysfunction. Foulds, S., Galustian, C., Mansfield, A.O., Schachter, M. Ann. Surg. (2001) [Pubmed]
  12. Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Gamrin, L., Essén, P., Hultman, E., McNurlan, M.A., Garlick, P.J., Wernerman, J. Ann. Surg. (2000) [Pubmed]
  13. The regional production of cytokines and lactate in sepsis-related multiple organ failure. Douzinas, E.E., Tsidemiadou, P.D., Pitaridis, M.T., Andrianakis, I., Bobota-Chloraki, A., Katsouyanni, K., Sfyras, D., Malagari, K., Roussos, C. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  14. Oxidative stress in the development of human ischemic hepatitis during circulatory shock. Biasi, F., Chiarpotto, E., Lanfranco, G., Capra, A., Zummo, U., Chiappino, I., Scavazza, A., Albano, E., Poli, G. Free Radic. Biol. Med. (1994) [Pubmed]
  15. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. Brandtzaeg, P., Kierulf, P., Gaustad, P., Skulberg, A., Bruun, J.N., Halvorsen, S., Sørensen, E. J. Infect. Dis. (1989) [Pubmed]
  16. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Gando, S., Kameue, T., Matsuda, N., Hayakawa, M., Ishitani, T., Morimoto, Y., Kemmotsu, O. Thromb. Haemost. (2002) [Pubmed]
  17. Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. Delogu, G., Famularo, G., Amati, F., Signore, L., Antonucci, A., Trinchieri, V., Di Marzio, L., Cifone, M.G. Crit. Care Med. (1999) [Pubmed]
  18. Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Reid, C.L., Perrey, C., Pravica, V., Hutchinson, I.V., Campbell, I.T. Crit. Care Med. (2002) [Pubmed]
  19. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine. Thomas, N.J., Carcillo, J.A., Herzer, W.A., Mi, Z., Jackson, E.K. J. Pharmacol. Exp. Ther. (2001) [Pubmed]
  20. Tissue-specific gene expression of heme oxygenase-1 (HO-1) and non-specific delta-aminolevulinate synthase (ALAS-N) in a rat model of septic multiple organ dysfunction syndrome. Suzuki, T., Takahashi, T., Yamasaki, A., Fujiwara, T., Hirakawa, M., Akagi, R. Biochem. Pharmacol. (2000) [Pubmed]
  21. The role of phagocyte proteinases and proteinase inhibitors in multiple organ failure. Jochum, M., Gippner-Steppert, C., Machleidt, W., Fritz, H. Am. J. Respir. Crit. Care Med. (1994) [Pubmed]
  22. Sequential systemic platelet-activating factor and interleukin 8 primes neutrophils in patients with trauma at risk of multiple organ failure. Botha, A.J., Moore, F.A., Moore, E.E., Peterson, V.M., Silliman, C.C., Goode, A.W. The British journal of surgery. (1996) [Pubmed]
  23. Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Papathanassoglou, E.D., Moynihan, J.A., McDermott, M.P., Ackerman, M.H. Crit. Care Med. (2001) [Pubmed]
  24. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Pacher, R., Redl, H., Frass, M., Petzl, D.H., Schuster, E., Woloszczuk, W. Crit. Care Med. (1989) [Pubmed]
  25. Use of single-frequency bioimpedance at 50 kHz to estimate total body water in patients with multiple organ failure and fluid overload. Foley, K., Keegan, M., Campbell, I., Murby, B., Hancox, D., Pollard, B. Crit. Care Med. (1999) [Pubmed]
  26. Increased sensitivity of homozygous Sod2 mutant mice to oxygen toxicity. Asikainen, T.M., Huang, T.T., Taskinen, E., Levonen, A.L., Carlson, E., Lapatto, R., Epstein, C.J., Raivio, K.O. Free Radic. Biol. Med. (2002) [Pubmed]
  27. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Marty, C., Misset, B., Tamion, F., Fitting, C., Carlet, J., Cavaillon, J.M. Crit. Care Med. (1994) [Pubmed]
  28. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Gando, S., Kameue, T., Morimoto, Y., Matsuda, N., Hayakawa, M., Kemmotsu, O. Crit. Care Med. (2002) [Pubmed]
  29. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Grobmyer, S.R., Barie, P.S., Nathan, C.F., Fuortes, M., Lin, E., Lowry, S.F., Wright, C.D., Weyant, M.J., Hydo, L., Reeves, F., Shiloh, M.U., Ding, A. Crit. Care Med. (2000) [Pubmed]
  30. Plasma separation and bilirubin adsorption after complicated liver transplantation: a therapeutic approach to excessive hyperbilirubinemia. Ott, R., Rupprecht, H., Born, G., Müller, V., Reck, T., Hohenberger, W., Köckerling, F. Transplantation (1998) [Pubmed]
  31. Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass. el-Barbary, M., Khabar, K.S. Crit. Care Med. (2002) [Pubmed]
  32. High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan. Zwaveling, J.H., Maring, J.K., Clarke, F.L., van Ginkel, R.J., Limburg, P.C., Hoekstra, H.J., Koops, H.S., Girbes, A.R. Crit. Care Med. (1996) [Pubmed]
  33. Antithrombin III in hematopoietic stem cell transplantation. Haire, W.D. Semin. Thromb. Hemost. (1997) [Pubmed]
  34. Cortisol and catecholamine kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome. Tsubo, T., Hashimoto, Y., Araki, I., Ishihara, H., Matsuki, A. Intensive care medicine. (1996) [Pubmed]
WikiGenes - Universities